NeoMab Fully-human Antibody Transgenic Mouse

Introduction of NeoMab Fully-human Antibody Transgenic Mouse

NeoMab is a next-generation fully human antibody transgenic mouse model established by NeoMab Biotechnology. This model integrates the antibody coding genes for human heavy chain and kappa light chain variable region libraries in situ, while retaining the complete constant region and regulatory elements of BALB/c mice. This results in an immune response comparable to or even superior to that of BALB/c, making it highly suitable for the development of fully human antibodies.

Advantages of NeoMab

We Offer

Based on the fully human antibody transgenic mouse NeoMab platform, a variety of human modules such as IgG, ScFv, Fab, sdAb, and BsAb can be obtained, providing clients with product development services for ADCs, AOCs, single/double/multiple antibodies, nanobodies and cell therapies.
We offer a one-stop fully human antibody R&D service, from target validation to IND submission.
By screening fully human antibodies using NeoMab transgenic mice, we bypass the humanization process, saving time and costs. This approach synchronizes antibody selection with the development of in vivo animal models and experimental systems, significantly accelerating in vivo testing timelines and potentially reducing drug development cycles by up to 1.5 years for clients.

Simultaneously advance the construction of in vivo efficacy models and the validation of BMK

Save up to 1.5 years!

Learn MORE About Fully Human Antibody Discovery.